Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00518778 · ClinicalTrials.gov registry record
Fusariosis in Solid-Organ Transplant Recipients
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 50
- Enrollment target
NCT00518778: Completed study, sponsored by University of Pittsburgh.
NCT00518778 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00518778 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This exempt chart review study will try to determine the clinical presentation, prognostic factors, response to different treatment modalities and mortality among patients diagnosed with fusariosis after solid-organ transplantation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-08 |
| Est. Completion | 2009-12 |
What the finished NCT00518778 record still lists
NCT00518778 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00518778 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00518778 about?
NCT00518778 is a clinical study titled "Fusariosis in Solid-Organ Transplant Recipients". This exempt chart review study will try to determine the clinical presentation, prognostic factors, response to different treatment modalities and mortality among patients diagnosed with fusariosis after solid-organ transplantation.
What is the current status of trial NCT00518778?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2007-08. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00518778?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia